Abstract
Intra-arterial chemotherapy (IAC) has been described in the treatment of retinoblastoma [1–3], sarcoma [4, 5], and malignant glioma [6, 7]. Intra-arterial chemotherapy (IAC) in these settings has generally been considered adjuvant therapy along with systemic chemotherapy, surgical resection, and/or radiation therapy. IAC is appealing given the potential to limit systemic toxicity from chemotherapeutic agents while increasing the concentration in areas of active malignancy. Within the central nervous system, the blood brain barrier (BBB) has proven to be a hurdle to the delivery of chemotherapy agents with various protocols described to help breakdown the BBB to facilitate chemotherapy delivery [8]. Within the pediatric population, IAC for the treatment of retinoblastoma (Rb) has become well studied with a good safety profile and efficacy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Reese AB, Hyman GA, Tapley ND, Forrest AW. The treatment of retinoblastoma by x-ray and triethylene melamine. AMA Arch Ophthalmol. 1958;60(5):897–906.
Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol. 2004;9(2):69–73.
Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115(8):1398–404, 1404.e1.
Anderson PM, Pearson M. Novel therapeutic approaches in pediatric and young adult sarcomas. Curr Oncol Rep. 2006;8(4):310–5.
Wilkins RM, Cullen JW, Odom L, Jamroz BA, Cullen PM, Fink K, et al. Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity. Ann Surg Oncol. 2003;10(5):498–507.
Desjardins A, Rich JN, Quinn JA, Vredenburgh J, Gururangan S, Sathornsumetee S, et al. Chemotherapy and novel therapeutic approaches in malignant glioma. Front Biosci J Virtual Libr. 2005;10:2645–68.
Brambilla Bas M, Boccardo M. Intracarotid cisplatin chemotherapy for high-grade astrocytomas. J Neurosurg Sci. 1993;37(2):83–6.
Hall WA, Doolittle ND, Daman M, Bruns PK, Muldoon L, Fortin D, et al. Osmotic blood–brain barrier disruption chemotherapy for diffuse pontine gliomas. J Neurooncol. 2006;77(3):279–84.
Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 2009;93(1):21–3.
Chantada G, Schaiquevich P. Management of retinoblastoma in children: current status. Paediatr Drugs. 2015;17(3):185–98.
Broaddus E, Topham A, Singh AD. Survival with retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 2009;93(1):24–7.
Kaliki S, Shields CL. Retinoblastoma: achieving new standards with methods of chemotherapy. Indian J Ophthalmol. 2015;63(2):103–9.
Abramson DH, Marr BP, Brodie SE, Dunkel I, Palioura S, Gobin YP. Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review. PLoS ONE [Internet]. 2012 [Cited 10 June 2015];7(4). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335846/.
Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, et al. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol Chic Ill 1960. 2011;129(11):1399–406.
Bakhshi S, Meel R, Radhakrishnan V. Current therapy and recent advances in the management of retinoblastoma. Indian J Med Paediatr Oncol. 2012;33(2):80.
Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin N Am. 2005;18(1):41–53, viii.
Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113(12):2276–80.
Suzuki S, Yamane T, Mohri M, Kaneko A. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis. Ophthalmology. 2011;118(10):2081–7.
Francis JH, Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Jonna G, et al. Carboplatin ± topotecan ophthalmic artery chemosurgery for intraocular retinoblastoma. PLoS ONE [Internet]. 21 Aug 2013 [Cited 10 June 2015];8(8). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749169/.
Jabbour P, Chalouhi N, Tjoumakaris S, Gonzalez LF, Dumont AS, Chitale R, et al. Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma. J Neurosurg Pediatr. 2012;10(3):175–81.
Amans MR, Narvid J, Halbach VV. Intra-arterial chemotherapy for bilateral retinoblastoma via left ophthalmic artery and right anterior deep temporal artery. BMJ Case Rep. 2014;2014.
Saglam M, Sarici A, Anagnostakou V, Yildiz B, Kocer N, Islak C, et al. An alternative technique of the superselective catheterization of the ophthalmic artery for intra-arterial chemotherapy of the retinoblastoma: retrograde approach through the posterior communicating artery to the ophthalmic artery. Neuroradiology. 2014;56(9):751–4.
Abruzzo T, Patino M, Leach J, Rahme R, Geller J. Cerebral vasoconstriction triggered by sympathomimetic drugs during intra-atrerial chemotherapy. Pediatr Neurol. 2013;48(2):139–42.
Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol Chic Ill 1960. 2011;129(6):732–7.
Sarici A, Kizilkilic O, Celkan T, Gode S. Blue toe syndrome as a complication of intra-arterial chemotherapy for retinoblastoma. JAMA Ophthalmol. 2013;131(6):801–2.
Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. J Neurosurg. 2011;114(6):1603–8.
Kato MA, Green N, O’Connell K, Till SD, Kramer DJ, Al-Khelaifi M, et al. A retrospective analysis of severe intraoperative respiratory compliance changes during ophthalmic arterial chemosurgery for retinoblastoma. Pediatr Anesth. 2015;25(6):595–602.
Phillips TJ, McGuirk SP, Chahal HK, Kingston J, Robertson F, Brew S, et al. Autonomic cardio-respiratory reflex reactions and superselective ophthalmic arterial chemotherapy for retinoblastoma. Pediatr Anesth. 2013;23(10):940–5.
Shields CL, Bianciotto CG, Jabbour P, Griffin GC, Ramasubramanian A, Rosenwasser R, et al. Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications. Arch Ophthalmol Chic Ill 1960. 2011;129(11):1407–15.
Eagle RC, Shields CL, Bianciotto C, Jabbour P, Shields JA. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol Chic Ill 1960. 2011;129(11):1416–21.
Vijayakrishnan R, Shields CL, Ramasubramanian A, Emrich J, Rosenwasser R, Shields JA. Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned? Arch Ophthalmol Chic Ill 1960. 2010;128(11):1427–31.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
He, L.L., Thomas, A.J., Ogilvy, C.S. (2016). Intra-arterial Delivery of Chemotherapeutic Agents. In: Agrawal, A., Britz, G. (eds) Pediatric Vascular Neurosurgery. Springer, Cham. https://doi.org/10.1007/978-3-319-43636-4_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-43636-4_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43634-0
Online ISBN: 978-3-319-43636-4
eBook Packages: MedicineMedicine (R0)